M. Esposito et al., Human transaldolase and cross-reactive viral epitopes identified by autoantibodies of multiple sclerosis patients, J IMMUNOL, 163(7), 1999, pp. 4027-4032
Multiple sclerosis is mediated by an autoimmune process causing selective d
estruction of oligodendrocytes, Transaldolase, which is expressed in the br
ain selectively in oligodendrocytes, is a target of high affinity autoantib
odies in serum and cerebrospinal fluid of multiple sclerosis patients. A th
ree-dimensional model of human transaldolase was developed based on the cry
stal structure of the enzyme from Escherichia coli. To identify immunodomin
ant epitopes, 33 peptides overlapping human transaldolase by 5 amino acids
were synthesized. Ab 12484, raised against enzymatically active human trans
aldolase, recognized antigenic determinants corresponding to linear epitope
s (residues 27-31 and 265-290) and rx helices (residues 75-98 and 302-329),
Four immunodominant peptides harboring charged amino acid residues with to
pographically exposed side chains were identified by sera from 13 multiple
sclerosis patients with predetermined autoreactivity to transaldolase, Auto
antibodies binding to the most prominent human transaldolase epitope, betwe
en residues 271 and 285, showed cross-reactivity with Epstein-Barr and herp
es simplex virus type 1 capsid-derived peptides. Molecular mimicry between
immunodominant autoepitopes and viral Ags may be a decisive factor in direc
ting autoimmunity to transaldolase in multiple sclerosis patients.